Anticholinergics, processes for preparing them, and pharmaceutical compositions containing them
First Claim
Patent Images
1. A compound of formula 1wherein:
- A is a group selected from
X−
is an anion with a single negative charge;
R1 and R2 are each independently a C1-C4-alkyl optionally substituted with hydroxy or halogen;
R3 and R5 are each independently fluorine, chlorine, or bromine; and
R4, R6, R7, and R8 are each independently hydrogen, fluorine, chlorine, or bromine.
1 Assignment
0 Petitions
Accused Products
Abstract
A compound of formula 1
wherein:
- A is a group selected from
- X− is an anion with a single negative charge;
- R1 and R2 are each independently a C1-C4-alkyl optionally substituted with hydroxy or halogen; and
- R3, R4, R5, R6, R7, and R8 are each independently hydrogen, C1-C4-alkyl, C1-C4-alkyloxy, hydroxy, CF3, CN, NO2, or halogen,
with the proviso that at least one of the groups R3, R4, R5, R6, R7, and R8 is not hydrogen, processes for preparing these compounds, pharmaceutical compositions containing these compounds, and their use as pharmaceutical compositions.
20 Citations
17 Claims
-
1. A compound of formula 1
wherein: -
A is a group selected from X−
is an anion with a single negative charge;
R1 and R2 are each independently a C1-C4-alkyl optionally substituted with hydroxy or halogen;
R3 and R5 are each independently fluorine, chlorine, or bromine; and
R4, R6, R7, and R8 are each independently hydrogen, fluorine, chlorine, or bromine. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12)
-
-
13. A compound of formula 4
wherein: -
A is a group selected from R1 is a C1-C4-alkyl optionally substituted with hydroxy or halogen;
R3 and R5 are each independently fluorine, chlorine, or bromine; and
R4, R6, R7, and R8 are each independently hydrogen, fluorine, chlorine, or bromine. - View Dependent Claims (14, 15, 16, 17)
-
Specification
-
- Resources
Litigation Campaign Assessment
Thank you for your request. You will receive a custom alert email when the Litigation Campaign Assessment is available.
×
-
Current AssigneeBoehringer Ingelheim Pharmaceuticals Incorporated (C.H. Boehringer Sohn AG & Co. KG)
-
Original AssigneeBoehringer Ingelheim Pharma GmbH & Company Kg (C.H. Boehringer Sohn AG & Co. KG)
-
InventorsPieper, Michael Paul, Morschhaeuser, Gerd, Meissner, Helmut, Speck, Georg, Pohl, Gerald, Reichl, Richard
-
Primary Examiner(s)Huang, Evelyn Mei
-
Application NumberUS09/965,766Publication NumberTime in Patent Office1,229 DaysField of Search546/131, 546/91, 514/304, 514/291US Class Current514/291CPC Class CodesA61P 11/06 AntiasthmaticsA61P 13/06 Anti-spasmodicsC07D 451/10 acylated by aliphatic or ar...C07D 451/14 containing 9-azabicyclo [3....
